Contact information
Research groups
Lucy Eldridge
Head of Data Collection Systems
As OCTRU's Head of Data Collection Systems, I manage the database team within OCTRU IT, primarily responsible for providing clinical databases to our trial teams. This involves building eCRFs, randomisation systems, writing reports, and setting up public facing trial websites. We also run the online helpdesk.
In addition, I provide systems training to our users, and I've been involved in a number of IT projects, such as designing an online therapeutic training programme which has been completed by just under a thousand clinicians to date. I'm interested in finding innovative solutions to common data issues.
Before joining OCTRU in September 2015, I graduated with a degree in Human Sciences (University of Oxford), and worked as Database Officer for the Blavatnik School of Government for eight months. In this role I helped shape a new contacts database, and trained other staff in how to use it.
Recent publications
-
Impact of nutritional status on pathological response and recurrence-free survival in locally advanced oesophagogastric adenocarcinoma treated with perioperative FLOT therapy
Journal article
Sugiyama K. et al, (2025), Esmo gastrointestinal oncology, 9
-
Temporary 2-week suspension of methotrexate treatment to enhance COVID-19 vaccine response in people with immune-mediated inflammatory diseases: the VROOM RCT
Journal article
Abhishek A. et al, (2025), Efficacy and mechanism evaluation, 1 - 42
-
Effect of a 2-week interruption in methotrexate treatment on COVID-19 vaccine response in people with immune-mediated inflammatory diseases (VROOM study): a randomised, open label, superiority trial
Journal article
Abhishek A. et al, (2025), Efficacy and mechanism evaluation, 12, 47 - 48
-
Effect of a 2-week interruption in methotrexate treatment versus continued treatment on COVID-19 booster vaccine immunity in adults with inflammatory conditions (VROOM study): a randomised, open label, superiority trial
Journal article
Abhishek A. et al, (2025), Efficacy and mechanism evaluation, 12, 45 - 46
-
Effects of temporarily suspending low-dose methotrexate treatment for 2 weeks after SARS-CoV-2 vaccine booster on vaccine response in immunosuppressed adults with inflammatory conditions: protocol for a multicentre randomised controlled trial and nested mechanistic substudy (Vaccine Response On/Off Methotrexate (VROOM) study)
Journal article
Abhishek A. et al, (2025), Efficacy and mechanism evaluation, 12, 43 - 44